Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy

Figure 2

The 5-year incidence of total MACE and each component according to the achieved LDL-C and followed-up hsCRP. Subgroup analysis of the adjusted HR for the 5-year incidence of total death, AMI and cardiac death, de novo PCI, atrial fibrillation, heart failure, and stroke according to achieved LDL-C level and followed-up hsCRP level during the 5-year follow-up period, after moderate intensity of statin therapy. MACE; major adverse cardiovascular event, LDL-C; low density lipoprotein cholesterol, hsCRP; high-sensitivity C-reactive protein, HR; hazard ratio, CI; confidential intervals, Q; quartile, AMI; acute myocardial infarction, PCI; percutaneous coronary intervention.